Current management of atopic dermatitis and interruption of the atopic march.

Mark Boguniewicz, Lawrence F Eichenfield, Thomas Hultsch

Journal: The Journal of allergy and clinical immunology 2004;112(6 Suppl):S140-50

PMID: 14657844

Full Text on Elsevier Science View on PubMed

Abstract

Treatment of atopic dermatitis requires a comprehensive approach that includes evaluation of potential triggers and education of the patient and family regarding proper avoidance measures. Hydration of the skin and maintenance of an intact skin barrier remain integral to proper management. Although topical corticosteroids have been a mainstay of anti-inflammatory therapy, the newer topical calcineurin inhibitors offer advantages for treatment of this chronic, relapsing disease. Studies aimed at defining optimal combination therapy and early intervention might change the treatment paradigm for atopic dermatitis.

Address: Division of Pediatric Allergy-Immunology, National Jewish Medical Research Center and University of Colorado School of Medicine, Denver, Colorado 80206, USA.

DOI: 10.1016/j.jaci.2003.09.031

Link outs

Free resources

Other Literature Sources:

https://www.lens.org/lens/search/patent/list?q=ref...

Subscription / membership required

Full Text Sources:

MeSH Terms: Anti-Inflammatory Agents, Asthma, Calcineurin, Calcineurin Inhibitors, Dermatitis, Atopic, Dermatologic Agents, Disease Management, Disease Progression, Humans, Prevalence, Skin Care